Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.

By Peter Libby, P. Ridker. American Journal of Medicine, 2004

630 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/12e4da330e2f4d079bb53afdfd86807ff65e2a43

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. R. Goldberg
2. Peter Libby

In Epidemiology

1. R. Goldberg
2. Peter Libby
3. P. Ridker

In Surgery

1. R. Goldberg
2. Peter Libby
3. I. Tabas
4. A. Lichtman

Citations in the corpus

• Inflammation and cardiovascular disease mechanisms. (2006, background): “CRP has many advantages as a marker: it is stable, has negligible circadian variation, and is easily and reliably measured (43).”
• Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. (2009, background): “3172 Goldberg Biomarkers in Diabetes J Clin Endocrinol Metab, September 2009, 94(9):3171–3182”